Octreotide microspheres to prevent pancreas surgery complications
Part of Digestive system clinical trials.
This trial tests whether a drug called octreotide microspheres can help prevent a common complication after surgery to remove part of the pancreas. If you are scheduled for this type of surgery, this study may help reduce your risk of developing a leak from the pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled to have surgery to remove the tail part of your pancreas (distal pancreatectomy), and your doctor says the tumor or condition is removable by surgery.
- You have not had pancreatic surgery before.
- You do not have serious liver disease, active hepatitis, or uncontrolled infections.
- You are not allergic to somatostatin or similar drugs, and you have not taken long-acting versions of these drugs before.
- If you are of childbearing age or have a partner of childbearing age, you agree to use reliable birth control during the study and for 120 days after, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a short course of radiation before surgery can lower the risk of a pancreatic leak (a common complication). It is for people who are overweight, older than 45, and have a small pancreatic duct.
This trial looks at factors that can predict a serious complication called a pancreatic fistula (a leak from the pancreas) after a Whipple procedure. The goal is to help doctors better understand and manage this risk.
This trial studies whether injecting a Botox-like medicine into the pancreatic drainage area can help prevent a post-surgery pancreas fistula (a persistent leak). It’s for adults having a planned distal pancreatectomy, and it may help reduce complications after surgery.
This trial tests if a medicine called lanreotide, given before surgery, can prevent a common complication (pancreatic leak) after removing part of the pancreas. It is for people with pancreatic cancer or a growth that could become cancer who are scheduled for a specific type of pancreas surgery.
This Phase 1/2 study tests whether adding an islet (insulin-producing cell) transplant at the time of pancreatic-region surgery is safe and helps prevent a serious surgical complication called a postoperative fistula. It is for people whose surgery is considered high risk for developing that complication.
This trial tests whether giving a combination of three treatments—hydrocortisone (a steroid), octreotide (a drug that reduces digestive fluids), and a tissue patch—before and during pancreatic surgery can help prevent complications. It is for people with a very small pancreatic duct (3 mm or less) who are scheduled for pancreatic surgery.
Hear when a new Pancreatic Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.